Search the collection

90 results for Heterocyclic+Compounds,+1-Ring+-+therapeutic+use

Sort by:

Sort by

Limit results to:

20 per page

90 results for Heterocyclic+Compounds,+1-Ring+-+therapeutic+use

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 21
ArticlesPeer ReviewedFull Text
Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer
Author / Creator:Kabasakal, Levent ; AbuQbeitah, Mohammad ; Aygün, Aslan ; Yeyin, Nami ; Ocak, Meltem ; Demirci, Emre ; Toklu, Turkay
Publisher:Germany
Journal title:European journal of nuclear medicine and molecular imaging, 2015-12, Vol.42 (13), p.1976-1983
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 22
ArticlesPeer ReviewedFull Text
Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer
Author / Creator:Yordanova, Anna ; Linden, Paula ; Hauser, Stefan ; Meisenheimer, Michael ; Kürpig, Stefan ; Feldmann, Georg ; Gaertner, Florian C. ; Essler, Markus ; Ahmadzadehfar, Hojjat
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:European journal of nuclear medicine and molecular imaging, 2019-05, Vol.46 (5), p.1073-1080
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 23
ArticlesPeer ReviewedFull Text
Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand the...
Author / Creator:Rosar, Florian ; Wenner, Felix ; Khreish, Fadi ; Dewes, Sebastian ; Wagenpfeil, Gudrun ; Hoffmann, Manuela A. ; Schreckenberger, Mathias ; Bartholomä, Mark ; Ezziddin, Samer
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:European journal of nuclear medicine and molecular imaging, 2022-04, Vol.49 (5), p.1584-1594
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 24
ArticlesPeer ReviewedFull Text
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer
Author / Creator:Zang, Jie ; Wang, Guochang ; Zhao, Tianzhi ; Liu, Huipan ; Lin, Xiuting ; Yang, Yun ; Shao, Zezhong ; Wang, Chao ; Chen, Haojun ; Chen, Yue ; Zhu, Zhaohui ; Miao, Weibing ; Chen, Xiaoyuan ; Zhang, Jingjing
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:European journal of nuclear medicine and molecular imaging, 2024-02, Vol.51 (3), p.871-882
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 25
ArticlesPeer ReviewedFull Text
A step closer to the use of [ 177Lu]Lu-PSMA-617 in metastatic hormone-sensitive prostate cancer
Author / Creator:Jia, Angela Y ; Spratt, Daniel E
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2024-10, Vol.25 (10), p.1246-1247
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 26
ArticlesPeer ReviewedFull Text
The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer
Author / Creator:Yordanova, Anna ; Becker, Anja ; Eppard, Elisabeth ; Kürpig, Stefan ; Fisang, Christian ; Feldmann, Georg ; Essler, Markus ; Ahmadzadehfar, Hojjat
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:European journal of nuclear medicine and molecular imaging, 2017-08, Vol.44 (9), p.1473-1479
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 27
ArticlesPeer ReviewedFull Text
[ 161 Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [ 177 Lu]Lu-PSMA-617
Author / Creator:Schaefer-Schuler, Andrea ; Burgard, Caroline ; Blickle, Arne ; Maus, Stephan ; Petrescu, Christine ; Petto, Sven ; Bartholomä, Mark ; Stemler, Tobias ; Ezziddin, Samer ; Rosar, Florian
Publisher:Australia: Ivyspring International Publisher
Journal title:Theranostics, 2024-01, Vol.14 (5), p.1829-1840
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 28
ArticlesPeer ReviewedFull Text
Single-dose 177 Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Author / Creator:Aggarwal, Rahul ; Starzinski, Stephanie ; de Kouchkovsky, Ivan ; Koshkin, Vadim ; Bose, Rohit ; Chou, Jonathan ; Desai, Arpita ; Kwon, Daniel ; Kaushal, Samuel ; Trihy, Lauren ; Rastogi, Medini ; Ippisch, Robin ; Aslam, Maya ; Friedlander, Terence ; Feng, Felix ; Oh, David ; Cheung, Alexander ; Small, Eric ; Evans, Michael ; Fong, Lawrence ; Hope, Thomas A
Publisher:England: Elsevier Limited
Journal title:The lancet oncology, 2023-11, Vol.24 (11), p.1266
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 29
ArticlesPeer ReviewedFull Text
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up
Author / Creator:Hartrampf, Philipp E. ; Seitz, Anna Katharina ; Weinzierl, Franz-Xaver ; Serfling, Sebastian E. ; Schirbel, Andreas ; Rowe, Steven P. ; Kübler, Hubert ; Buck, Andreas K. ; Werner, Rudolf A.
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:European journal of nuclear medicine and molecular imaging, 2022-10, Vol.49 (12), p.4262-4270
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 30
ArticlesPeer ReviewedFull Text
Novel therapies are changing treatment paradigms in metastatic prostate cancer
Author / Creator:Powers, Eric ; Karachaliou, Georgia Sofia ; Kao, Chester ; Harrison, Michael R. ; Hoimes, Christopher J. ; George, Daniel J. ; Armstrong, Andrew J. ; Zhang, Tian
Publisher:England: BioMed Central Ltd
Journal title:Journal of hematology and oncology, 2020-10, Vol.13 (1), p.144-144, Article 144
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 31
ArticlesPeer ReviewedFull Text
(18)F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617
Author / Creator:Giesel, Frederik L ; Cardinale, Jens ; Schäfer, Martin ; Neels, Oliver ; Benešová, Martina ; Mier, Walter ; Haberkorn, Uwe ; Kopka, Klaus ; Kratochwil, Clemens
Publisher:Germany
Journal title:European journal of nuclear medicine and molecular imaging, 2016-09, Vol.43 (10), p.1929-1930
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 32
ArticlesPeer ReviewedFull Text
Alpha emitter isotopes and PSMA ligands: the near future therapeutic prospective for castration-resistant prostate cancer
Author / Creator:Volpe, Fabio ; Piscopo, Leandra ; Zampella, Emilia ; Klain, Michele
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:European journal of nuclear medicine and molecular imaging, 2024-04, Vol.51 (5), p.1207-1209
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 33
ArticlesPeer ReviewedFull Text
Adoption of Lutetium-177 PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020
Author / Creator:Flegar, Luka ; Thoduka, Smita George ; Librizzi, Damiano ; Luster, Markus ; Zacharis, Aristeidis ; Heers, Hendrik ; Eisenmenger, Nicole ; Ahmadzadehfar, Hojjat ; Eiber, Matthias ; Weber, Wolfgang ; Groeben, Christer ; Huber, Johannes
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:European journal of nuclear medicine and molecular imaging, 2023-06, Vol.50 (7), p.2188-2195
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 34
ArticlesPeer ReviewedFull Text
[177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study
Author / Creator:Satapathy, Swayamjeet ; Yadav, Madhav Prasad ; Ballal, Sanjana ; Sahoo, Ranjit Kumar ; Bal, Chandrasekhar
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:European journal of nuclear medicine and molecular imaging, 2024-07, Vol.51 (8), p.2495-2503
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 35
ArticlesPeer ReviewedFull Text
177 Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomi...
Author / Creator:Morris, Michael J ; Castellano, Daniel ; Herrmann, Ken ; de Bono, Johann S ; Shore, Neal D ; Chi, Kim N ; Crosby, Michael ; Piulats, Josep M ; Fléchon, Aude ; Wei, Xiao X ; Mahammedi, Hakim ; Roubaud, Guilhem ; Študentová, Hana ; Nagarajah, James ; Mellado, Begoña ; Montesa-Pino, Álvaro ; Kpamegan, Euloge ; Ghebremariam, Samson ; Kreisl, Teri N ; Wilke, Celine ; Lehnhoff, Katja ; Sartor, Oliver ; Fizazi, Karim
Publisher:England: Elsevier Limited
Journal title:The Lancet (British edition), 2024-09, Vol.404 (10459), p.1227
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 36
ArticlesPeer ReviewedFull Text
MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer’s disease
Author / Creator:Ringland, Charis ; Schweig, Jonas Elias ; Eisenbaum, Maxwell ; Paris, Daniel ; Ait-Ghezala, Ghania ; Mullan, Michael ; Crawford, Fiona ; Abdullah, Laila ; Bachmeier, Corbin
Publisher:England: BioMed Central Ltd
Journal title:BMC neuroscience, 2021-05, Vol.22 (1), p.39-39, Article 39
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 37
ArticlesPeer ReviewedFull Text
Combining enzalutamide and [ 177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
Author / Creator:Houédé, Nadine ; Hebert, Kevin
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2024-05, Vol.25 (5), p.531-533
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 38
ArticlesPeer ReviewedFull Text
Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy
Author / Creator:Widjaja, Liam ; Werner, Rudolf A. ; Krischke, Elke ; Christiansen, Hans ; Bengel, Frank M. ; Bogdanova, Natalia ; Derlin, Thorsten
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:European journal of nuclear medicine and molecular imaging, 2023-01, Vol.50 (2), p.602-612
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 39
ArticlesPeer ReviewedFull Text
Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry
Author / Creator:Burgard, Caroline ; Hein, Connor ; Blickle, Arne ; Bartholomä, Mark ; Maus, Stephan ; Petto, Sven ; Schaefer-Schuler, Andrea ; Ezziddin, Samer ; Rosar, Florian
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:European journal of nuclear medicine and molecular imaging, 2024-02, Vol.51 (3), p.885-895
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 40
ArticlesPeer ReviewedFull Text
Prognostic value of baseline alkaline phosphatase of 177Lu‐PSMA radioligand therapy in metastatic castration‐resistant prostate cancer: A systematic review and meta‐analysis
Author / Creator:Zhang, Tianhe ; Li, Wuxue ; Wei, Haiyang ; Huang, Zhiheng ; Yang, Junkai ; Zeng, Hanyi ; Zhou, Zhiyong ; Zhao, Xinghua
Publisher:United States: Public Library of Science
Journal title:PloS one, 2024-12, Vol.19 (12), p.e0307826
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 21 to 40 of 90 results

Export record to excel

Export this record

Export record to excel

Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer

Export this record

Export record to excel

Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer

Export this record

Export record to excel

Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand the...

Export this record

Export record to excel

A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer

Export this record

Export record to excel

A step closer to the use of [ 177Lu]Lu-PSMA-617 in metastatic hormone-sensitive prostate cancer

Export this record

Export record to excel

The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer

Export this record

Export record to excel

[ 161 Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [ 177 Lu]Lu-PSMA-617

Export this record

Export record to excel

Single-dose 177 Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial

Export this record

Export record to excel

Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up

Export this record

Export record to excel

Novel therapies are changing treatment paradigms in metastatic prostate cancer

Export this record

Export record to excel

(18)F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617

Export this record

Export record to excel

Alpha emitter isotopes and PSMA ligands: the near future therapeutic prospective for castration-resistant prostate cancer

Export this record

Export record to excel

Adoption of Lutetium-177 PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020

Export this record

Export record to excel

[177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study

Export this record

Export record to excel

177 Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomi...

Export this record

Export record to excel

MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer’s disease

Export this record

Export record to excel

Combining enzalutamide and [ 177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer

Export this record

Export record to excel

Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy

Export this record

Export record to excel

Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry

Export this record

Export record to excel

Prognostic value of baseline alkaline phosphatase of 177Lu‐PSMA radioligand therapy in metastatic castration‐resistant prostate cancer: A systematic review and meta‐analysis

Refine your search